Mynvax

Mynvax is a company headquartered in India. Brouky classifies it under Healthcare & Life Sciences.

Mynvax is a clinical stage vaccine biotechnology company that develops novel, thermostable recombinant vaccines targeting respiratory viral infections, including COVID-19, with a focus on accessibility for low and lower-middle-income countries.